Logo image of 1ZTS.MI

ZOETIS INC (1ZTS.MI) Stock Overview

Europe - BIT:1ZTS - US98978V1035 - Common Stock

125.64 EUR
+1.12 (+0.9%)
Last: 10/23/2025, 7:00:00 PM

1ZTS.MI Key Statistics, Chart & Performance

Key Statistics
Market Cap55.68B
Revenue(TTM)9.38B
Net Income(TTM)2.61B
Shares443.18M
Float442.76M
52 Week HighN/A
52 Week LowN/A
Yearly Dividend1.49
Dividend Yield1.31%
EPS(TTM)5.35
PE23.48
Fwd PE21.02
Earnings (Next)11-04 2025-11-04/bmo
IPO2013-02-01
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


1ZTS.MI short term performance overview.The bars show the price performance of 1ZTS.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20

1ZTS.MI long term performance overview.The bars show the price performance of 1ZTS.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of 1ZTS.MI is 125.64 EUR. In the past month the price decreased by -24.12%.

ZOETIS INC / 1ZTS Daily stock chart

1ZTS.MI Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
1LLY.MI ELI LILLY & CO 50.77 667.44B
LLY.DE ELI LILLY & CO 50.9 669.15B
ZEG.DE ASTRAZENECA PLC 18.64 438.72B
JNJ.DE JOHNSON & JOHNSON 17.95 386.11B
1JNJ.MI JOHNSON & JOHNSON 17.98 386.78B
RHO.DE ROCHE HOLDING AG-BR 13.94 239.54B
1ROG.MI ROCHE HOLDING AG-GENUSSCHEIN 13.94 239.54B
SAN.PA SANOFI 14.35 215.09B
1SAN.MI SANOFI 14.19 212.63B
SNW.DE SANOFI 14.18 212.56B
NOT.DE NOVARTIS AG-REG 14.28 207.91B
1NOVN.MI NOVARTIS AG-REG 14.23 207.14B

About 1ZTS.MI

Company Profile

1ZTS logo image Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The company is headquartered in Parsippany, New Jersey and currently employs 13,800 full-time employees. The company went IPO on 2013-02-01. The firm is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The firm operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. The company directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The firm is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).

Company Info

ZOETIS INC

10 Sylvan Way

Parsippany NEW JERSEY US

Employees: 13800

1ZTS Company Website

1ZTS Investor Relations

Phone: 19738227000

ZOETIS INC / 1ZTS.MI FAQ

What does ZOETIS INC do?

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The company is headquartered in Parsippany, New Jersey and currently employs 13,800 full-time employees. The company went IPO on 2013-02-01. The firm is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The firm operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. The company directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The firm is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).


What is the current price of 1ZTS stock?

The current stock price of 1ZTS.MI is 125.64 EUR. The price increased by 0.9% in the last trading session.


Does ZOETIS INC pay dividends?

ZOETIS INC (1ZTS.MI) has a dividend yield of 1.31%. The yearly dividend amount is currently 1.49.


What is the ChartMill technical and fundamental rating of 1ZTS stock?

1ZTS.MI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


Where is ZOETIS INC (1ZTS.MI) stock traded?

1ZTS.MI stock is listed on the Euronext Milan exchange.


How many employees does ZOETIS INC have?

ZOETIS INC (1ZTS.MI) currently has 13800 employees.


Can you provide the market cap for ZOETIS INC?

ZOETIS INC (1ZTS.MI) has a market capitalization of 55.68B EUR. This makes 1ZTS.MI a Large Cap stock.


1ZTS.MI Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to 1ZTS.MI.


Chartmill TA Rating
Chartmill Setup Rating

1ZTS.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to 1ZTS.MI. While 1ZTS.MI belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1ZTS.MI Financial Highlights

Over the last trailing twelve months 1ZTS.MI reported a non-GAAP Earnings per Share(EPS) of 5.35. The EPS increased by 12.27% compared to the year before.


Industry RankSector Rank
PM (TTM) 27.83%
ROA 18.04%
ROE 52.48%
Debt/Equity 1.05
Chartmill High Growth Momentum
EPS Q2Q%12.82%
Sales Q2Q%4.19%
EPS 1Y (TTM)12.27%
Revenue 1Y (TTM)5.27%

1ZTS.MI Forecast & Estimates

24 analysts have analysed 1ZTS.MI and the average price target is 166.26 EUR. This implies a price increase of 32.33% is expected in the next year compared to the current price of 125.64.

For the next year, analysts expect an EPS growth of 8.41% and a revenue growth 2.87% for 1ZTS.MI


Analysts
Analysts79.17
Price Target166.26 (32.33%)
EPS Next Y8.41%
Revenue Next Year2.87%

1ZTS.MI Ownership

Ownership
Inst Owners98.55%
Ins Owners0.06%
Short Float %N/A
Short RatioN/A